Skip to content
value.today

Gelstat Corp.

GSAC
No market cap data
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

Gelstat Corp. timeline

2 events, 1996–2003
  1. 1996
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2003
  4. ✎
    Renamed Gelstat Corp
    Formerly Developed Technology Resource Inc.

Events of Gelstat Corp. from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

Not enough history yet.

Insider trading at Gelstat Corp.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$0
open market only
Insiders on file
2
since
Gelstat Corp.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Adrian Graham GoldfarbDirectorBuy+16.00 M——16.72 MForm 4
filed Adrian Graham GoldfarbDirectorBuy+8.00 M——24.72 MForm 4
filed Adrian Graham GoldfarbDirectorBuy+9.84 M——34.56 MForm 4
filed Adrian Graham GoldfarbDirectorBuy+53.21 M$0.010$532 K87.77 MForm 4
filed Adrian Graham GoldfarbDirectorOther-280,400——715,400Form 4
filed Adrian Graham GoldfarbDirectorOther-719,600——995,800Form 4
filed Adrian Graham GoldfarbDirectorOther-2.05 M——1.72 MForm 4
filed Gerald N. Kieft IIChief Executive Officer, 10% ownerBuyindirect+10,000$0.030$3008.16 MForm 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Events at Gelstat Corp.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Acquisition or sale completed 1 · Directors and officers 9 · Material agreement 3 · Agreement ended 1 · Unregistered share sale 1

Gelstat Corp.: events reported to the SEC
FiledWhat happenedFiling
Directors and officers8-K
Directors and officers8-K
Directors and officersMaterial agreementAgreement endedUnregistered share sale8-K
Directors and officers8-K
Directors and officers8-K
Material agreement8-K
Acquisition or sale completed8-K
Directors and officers8-K
Directors and officers8-K
Material agreement8-K
Directors and officers8-K
Directors and officers8-K

Source: SEC EDGAR, Form 8-K item numbers · as of May 2, 2007

Peer comparison · Pharmaceutical

CompanyMarket capP/ENet marginRev. growth
Gelstat Corp.🇺🇸————
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Amgen Inc.🇺🇸$249.2 B26.5×24.1%+9.9%
AstraZeneca PLC🇬🇧$242.6 B23.7×17.4%+8.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Profile updated:
Nov 4, 2026

Figures from value.today research, SEC filing.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Gelstat Corp.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Gelstat Corp.'s ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Gelstat Corp.? Suggest a correction